[
  {
    "ts": "2026-01-21T12:10:45+00:00",
    "headline": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported that AbbVie Inc. (NYSE:ABBV) is looking to deepen its push into the rapidly growing obesity-treatment market, outlining its plans at the JPMorgan Healthcare Conference. The company’s plans center on GUBamy, an amylin-mimetic weight-loss drug […]",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8d42e3f4-ae24-3a22-b2ad-17de10ae72cb",
      "content": {
        "id": "8d42e3f4-ae24-3a22-b2ad-17de10ae72cb",
        "contentType": "STORY",
        "title": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported that AbbVie Inc. (NYSE:ABBV) is looking to deepen its push into the rapidly growing obesity-treatment market, outlining its plans at the JPMorgan Healthcare Conference. The company’s plans center on GUBamy, an amylin-mimetic weight-loss drug […]",
        "pubDate": "2026-01-21T12:10:45Z",
        "displayTime": "2026-01-21T12:10:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QJoE63tFdMpnnrAbqprcaw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gi43WiQpLk0J.NMrpOdajw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ae3aff8170c32ab72e21b7d307dd751f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-looks-deepen-push-121045476.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "GUBRA.CO"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-21T14:02:00+00:00",
    "headline": "Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference",
    "summary": "SAN DIEGO, January 21, 2026--Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.",
    "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b028eac3-64bb-3971-aaca-c715dc8f6d5f",
      "content": {
        "id": "b028eac3-64bb-3971-aaca-c715dc8f6d5f",
        "contentType": "STORY",
        "title": "Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference",
        "description": "",
        "summary": "SAN DIEGO, January 21, 2026--Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California.",
        "pubDate": "2026-01-21T14:02:00Z",
        "displayTime": "2026-01-21T14:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed",
          "originalWidth": 1000,
          "originalHeight": 328,
          "caption": "Biocom’s Global Partnering & Investor Conference brings together over 500 investors and senior executives, including CEOs and heads of business development, biotech, and research and development from leading pharmaceutical, biotech and research organizations from over 20 countries. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities. Learn more and register: https://www.biocomglobalpartnering.org.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gA7YWJhDU8zLmyCnZeuToQ--~B/aD0zMjg7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed.cf.webp",
              "width": 1000,
              "height": 328,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zJiVOJSw7_VJMxhZmA2BmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cd0edc9343dd2e6691c3cef19f8e87ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biocom-announces-powerhouse-keynote-panel-140200849.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]